Show simple item record

dc.contributor.authorPatel, BV
dc.contributor.authorHaar, S
dc.contributor.authorHandslip, R
dc.contributor.authorAuepanwiriyakul, C
dc.contributor.authorLee, TM-L
dc.contributor.authorPatel, S
dc.contributor.authorHarston, JA
dc.contributor.authorHosking-Jervis, F
dc.contributor.authorKelly, D
dc.contributor.authorSanderson, B
dc.contributor.authorBorgatta, B
dc.contributor.authorTatham, K
dc.contributor.authorWelters, I
dc.contributor.authorCamporota, L
dc.contributor.authorGordon, AC
dc.contributor.authorKomorowski, M
dc.contributor.authorAntcliffe, D
dc.contributor.authorProwle, JR
dc.contributor.authorPuthucheary, Z
dc.contributor.authorFaisal, AA
dc.contributor.authorUnited Kingdom COVID-ICU National Service Evaluation
dc.date.accessioned2021-05-14T17:15:57Z
dc.date.available2021-03-18
dc.date.available2021-05-14T17:15:57Z
dc.date.issued2021-05-11
dc.identifier.citationPatel, B.V., Haar, S., Handslip, R. et al. Natural history, trajectory, and management of mechanically ventilated COVID-19 patients in the United Kingdom. Intensive Care Med (2021). https://doi.org/10.1007/s00134-021-06389-zen_US
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/71837
dc.description.abstractPURPOSE: The trajectory of mechanically ventilated patients with coronavirus disease 2019 (COVID-19) is essential for clinical decisions, yet the focus so far has been on admission characteristics without consideration of the dynamic course of the disease in the context of applied therapeutic interventions. METHODS: We included adult patients undergoing invasive mechanical ventilation (IMV) within 48 h of intensive care unit (ICU) admission with complete clinical data until ICU death or discharge. We examined the importance of factors associated with disease progression over the first week, implementation and responsiveness to interventions used in acute respiratory distress syndrome (ARDS), and ICU outcome. We used machine learning (ML) and Explainable Artificial Intelligence (XAI) methods to characterise the evolution of clinical parameters and our ICU data visualisation tool is available as a web-based widget ( https://www.CovidUK.ICU ). RESULTS: Data for 633 adults with COVID-19 who underwent IMV between 01 March 2020 and 31 August 2020 were analysed. Overall mortality was 43.3% and highest with non-resolution of hypoxaemia [60.4% vs17.6%; P < 0.001; median PaO2/FiO2 on the day of death was 12.3(8.9-18.4) kPa] and non-response to proning (69.5% vs.31.1%; P < 0.001). Two ML models using weeklong data demonstrated an increased predictive accuracy for mortality compared to admission data (74.5% and 76.3% vs 60%, respectively). XAI models highlighted the increasing importance, over the first week, of PaO2/FiO2 in predicting mortality. Prone positioning improved oxygenation only in 45% of patients. A higher peak pressure (OR 1.42[1.06-1.91]; P < 0.05), raised respiratory component (OR 1.71[ 1.17-2.5]; P < 0.01) and cardiovascular component (OR 1.36 [1.04-1.75]; P < 0.05) of the sequential organ failure assessment (SOFA) score and raised lactate (OR 1.33 [0.99-1.79]; P = 0.057) immediately prior to application of prone positioning were associated with lack of oxygenation response. Prone positioning was not applied to 76% of patients with moderate hypoxemia and 45% of those with severe hypoxemia and patients who died without receiving proning interventions had more missed opportunities for prone intervention [7 (3-15.5) versus 2 (0-6); P < 0.001]. Despite the severity of gas exchange deficit, most patients received lung-protective ventilation with tidal volumes less than 8 mL/kg and plateau pressures less than 30cmH2O. This was despite systematic errors in measurement of height and derived ideal body weight. CONCLUSIONS: Refractory hypoxaemia remains a major association with mortality, yet evidence based ARDS interventions, in particular prone positioning, were not implemented and had delayed application with an associated reduced responsiveness. Real-time service evaluation techniques offer opportunities to assess the delivery of care and improve protocolised implementation of evidence-based ARDS interventions, which might be associated with improvements in survival.en_US
dc.languageeng
dc.language.isoenen_US
dc.relation.ispartofIntensive Care Medicine
dc.rightsCreative Commons Attribution-NonCommercial 4.0 International License
dc.subjectARDSen_US
dc.subjectArtificial intelligenceen_US
dc.subjectCOVID-19en_US
dc.subjectMechanical ventilationen_US
dc.subjectMortality risken_US
dc.subjectProne positionen_US
dc.titleNatural history, trajectory, and management of mechanically ventilated COVID-19 patients in the United Kingdom.en_US
dc.typeArticleen_US
dc.rights.holder© 2021 The Author(s)
dc.identifier.doi10.1007/s00134-021-06389-z
pubs.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/33974106en_US
pubs.notesNot knownen_US
pubs.publication-statusPublished onlineen_US
dcterms.dateAccepted2021-03-18
rioxxterms.funderDefault funderen_US
rioxxterms.identifier.projectDefault projecten_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record